MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
NCT Number: NCT05875129
Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.
Looking for future studies?
Notify Me18 year–39 year
All sexes
Interventional
Not applicable
Washington D.C., District of Columbia, 20010, United States
Sleep is a complex biobehavioral event, impacted by interactions between the individual's physiology as well as their environment. Young adult cancer survivors (YACS; those between 18- 29 years of age) are a growing group of survivors, numbering close to 400,000 in the US. They are among those at highest risk for chronically insufficient sleep due to developmentally normative biological and social factors, compounded by their extensive medical treatment history. Cognitive-behavioral therapy for insomnia (CBT-I) is recommended by the American College of Physicians as gold standard treatment for insomnia disorder and has been successfully adapted for YACS. Fundamental CBT-I strategies can be implemented to change the problematic sleep behaviors that result in insufficient sleep among young adults. However, it is essential that these evidence-based strategies be deployed to be responsive to the specific barriers to sleep for YACS. This feasibility/acceptability study will test the use of an integrated VAVA that offers the opportunity to implement intervention strategies in a way that repeatedly gives YACS the chance to make the right decision with respect to their sleep health in real time.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognitive behavioral therapy for insomnia
Time frame: 14 days
Number of days that a participant interacted with the VAVA
Time frame: 14 days
Score on satisfaction subscale of Usability, Satisfaction, Ease of use (USE) scale
Medstar Health Research Institute
Other
Intervention for Chronic Insufficient Sleep in Young Adult Cancer Survivors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07667959
Cancer, Dyssomnias
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05977062
Cancer, Dyssomnias
Lyon, France
View Trial DetailsNCT05358951
Cancer, Dyssomnias
Boston, Massachusetts, United States
View Trial DetailsNCT06938802
Cancer, Dyssomnias
Tucson, Arizona, United States
View Trial Details